Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

AB SCIEX Receives Frost & Sullivan Award

Published: Thursday, September 12, 2013
Last Updated: Thursday, September 12, 2013
Bookmark and Share
AB SCIEX has been awarded the 2013 Global Market Share Leadership Award for Mass Spectrometry from Frost & Sullivan.

AB SCIEX is ranked #1 in the mass spectrometry technology industry once again, according to an independent market research firm that tracks revenues and unit sales globally in the highly competitive sector of scientific instrumentation.  

The following are excerpts from the Frost & Sullivan report that accompanied the award, which was formally presented to AB SCIEX representatives last night at a gala event in San Jose, California:

• Staying Ahead of the Competition:  “AB Sciex has established an aggressive and successful R&D strategy to remain a step ahead of its competitors.”

• Innovation with the Highest Value: “The firm continues to focus on innovation and new product development to advance the field of mass spectrometry and make the technology more accessible on both ends of the budget spectrums.”

• Best-in-Class Instrumentation:  “AB Sciex’s highest performing 6500 Series is now widely considered the industry’s top-selling high-end triple quadrupole, setting benchmarks in sensitivity and performance.” 

• Leader Who Listens:  “By listening to and understanding the rapidly changing needs of its customers, AB Sciex has been able to build a product line that achieves unmatched sensitivity and performance, while making the technology accessible to the masses.”

• Largest Installed Base Worldwide:  “By developing a trusted and well-established line of high-quality instruments and software, combined with a feverish pace of technology improvement, AB Sciex will retain its status as the most widely-used portfolio of mass spectrometers.”

• Navigating to Meet Market Demand: “During a slow economy where capital equipment budgets have been slashed, the ability to bring cutting-edge high-end technologies to market, and find a willing marketplace, is a testament to the industry’s demand for AB Sciex systems.”  

• Continued Leadership: “With a trusted brand name, updated cutting-edge products, and a sole focus on being the premier provider of mass spectrometry tools, AB Sciex is expected to maintain its firm grip of the market share lead.”  

“We are extremely pleased by the independent confirmation of our leadership in the mass spectrometry industry,” said Rainer Blair, President of AB SCIEX.  “When scientists, lab managers and technologists consider mass spectrometry to help them achieve their goals, AB SCIEX should be the first place they look for all the reasons that the Frost & Sullivan market report details.  We’ve been a leader in mass spectrometry for decades and we intend to stay the leader through continued innovation and the industry’s best service and support.”   

The full report from Frost & Sullivan can be downloaded below.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

AB SCIEX Wins New Product Innovation Award in Asia Pacific
The award recognizes the company’s continued innovation in the mass spectrometry industry and a number of new products introduced into the market in recent years.
Thursday, October 30, 2014
AB SCIEX Announces In Vitro Diagnostic Devices CE Marked for Europe
AB SCIEX launches the 3200MD CE-IVDD series for general in vitro diagnostic use in Europe.
Tuesday, May 21, 2013
AB SCIEX Achieves ISO 13485 Certification for Manufacturing of LC/MS Systems
This ISO certification is often considered a first step toward complying with European regulatory requirements for a device to be cleared for use in the clinic.
Monday, February 27, 2012
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Signature of Microbiomes Linked to Schizophrenia
Studying microbiomes in throat may help identify causes and treatments of brain disorder.
Imaging Software Could Speed Breast Cancer Diagnosis
Technology could improve access to diagnostic services in developing countries.
Data Mining DNA For Polycystic Ovary Syndrome Genes
A new Northwestern Medicine genome-wide association study of PCOS – the first of its kind to focus on women of European ancestry – has provided important new insights into the underlying biology of the disorder.
Algorithm Interprets Breathing Difficulties to Aid in Medical Care
Researchers from North Carolina State University have developed an efficient algorithm that can interpret the wheezing of patients with breathing difficulties to give medical providers information about what’s happening in the lungs.
Researchers Develop qPCR Prognosis Test for NSCLC Patients
A nine-gene molecular prognostic index (MPI) for patients with early-stage non-small cell lung cancer (NSCLC) was able to provide accurate survival stratification and could potentially inform the use of adjuvant therapy in patients struggling with the disease.
Genetic Test Could Improve Blood Cancer Treatment
Testing for genetic risk factors could improve treatment for myeloma – a cancer of the blood and bone marrow – by helping doctors identify patients at risk of developing more aggressive disease.
PTR-MS Breath Test Shows Potential for Detecting Liver Disease
Researchers at the University of Birmingham have published results that suggest a non-invasive breath test for liver disease using an IONICON PTR-MS.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!